SafeHeal Diverting Ileostomy Pivotal Study
Public ClinicalTrials.gov record NCT06152276. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
SafeHeal Diverting Ileostomy Pivotal Study (SH-SOC23)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This SafeHeal study is designed to assess the overall safety of the low anterior resection (LAR) standard of care cancer treatment by establishing a definition of major complications. The current literature on standard of care reports adverse events/complications but does not provide a single endpoint that can be used to compare the safety of LAR cancer treatment to alternative therapies or treatments. This study will allow for the establishment of a new single safety endpoint for LAR standard of care cancer treatment.
Study identification
- NCT ID
- NCT06152276
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 132 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1, 2024 (Actual)
- Primary completion
- Jan 30, 2026 (Actual)
- Completion
- Jan 30, 2026 (Actual)
- Last update posted
- May 4, 2026
2024 – 2026
United States locations
- U.S. sites
- 15
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente - Los Angeles | Los Angeles | California | 90027 | — |
| Keck Medicine of USC | Los Angeles | California | 90033 | — |
| USC Keck Hospital | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| University of Miami | Miami | Florida | 33146 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| UMass Memorial Medical Center | Worcester | Massachusetts | 01605 | — |
| Maimonides Medical Center | Brooklyn | New York | 11219 | — |
| Mount Sinai Hospital | New York | New York | 10029 | — |
| New York Presbyterian Cornell | New York | New York | 10065 | — |
| Lenox Hill Hospital | New York | New York | 10075 | — |
| Novant Health | Winston-Salem | North Carolina | 27103 | — |
| Lankenau Medical Center | Wynnewood | Pennsylvania | 19096 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06152276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06152276 live on ClinicalTrials.gov.